Observational studyNutrition journal2026
Link between ultra-processed foods and drinks intake, gut microbiota and inflammation: an exploratory analysis in adult volunteers.
Observational study in Nutrition journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05949411 (Development of Non-invasive Methods to Study Gut Microbiome - Nutrition - Host Interactions), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development of Non-invasive Methods to Study Gut Microbiome - Nutrition - Host Interactions
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUltra-processed foods and drinks (UPFD) have been acknowledged to promote metabolic disturbances and inflammation. Knowing that both events can be associated with gut microbiota alterations, this observational longitudinal analysis aimed to explore the link between UPFD intake, faecal microbiota composition and activity, and inflammatory biomarkers.
methodsMICROBOOST-1 study included 20 adults for 3 study visits spaced at least 7 days apart. Dietary intakes were collected using three non-consecutive 24 h recalls, including a weekend day, and performed the week preceding each study visit. Foods and drinks were categorized in a double-blind manner as ultra-processed following the NOVA classification. Mean energy-adjusted UPFD consumption was then divided into quartiles. Stool samples were collected at most four days before each study visit. Faecal microbiota composition was analysed using 16S-rDNA Illumina sequencing, and exhaled breath hydrogen - reflecting gut microbial fermentation - was measured. Inflammatory cytokines were quantified in saliva. Mixed models were applied accounting for multiple time points per participant. Overall UPFD, "meat, fish, and cheese" (MFC) and "sugar-sweetened beverages" (SSB) categories were investigated.
resultsIn comparison with the lowest consumption quartile of UPFD categories, the highest quartile showed no change in α- and β-diversity, but a lower relative abundance of Faecalibacterium, Desulfovibrio, Veillonella and a higher relative abundance of Hominimerdicola and Phocaeicola for all UPFD (q-value < 0.05). A decrease in Agathobacter and Coprococcus and an increase in Actinomyces relative abundances characterized the MFC category, whereas higher Actinomyces and lower Flintibacter relative abundances were observed for SSB category (q-value < 0.05). SSB intake was also related to lower exhaled hydrogen and to higher salivary level of IL-6 (p-value < 0.05). Total UPFD intake was linked to increased salivary IL-1β (p-value < 0.05). This cytokine was positively associated with Flintibacter and negatively associated with Faecalibacterium. In addition, Phocaeicola, Desulfovibrio, Veillonella, Actinomyces and Coprococcus were positively associated with IL-6, while Desulfovibrio and Veillonella were positively and Actinomyces and Agathobacter negatively related to IL-8 (p-value < 0.05).
conclusionIn our study, using non-invasive tools, we observed associations between the level of UPFD intake and components of the gut microbiota and inflammation. CLINICAL TRIAL NUMBER: The protocol is recorded at «clinicaltrials.gov» (NCT05949411).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.